Hearing Loss Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have a pulsating/whooshing sound in your ear (called pulsatile tinnitus) that significantly affects your daily life
- A scan has confirmed that your tinnitus is caused by an abnormal connection between arteries and veins near your brain, called a dural arteriovenous fistula (DAVF)
- Your DAVF is a mild type (Type I or IIa based on a standard medical classification system) as confirmed by a specialised blood vessel scan
- Your DAVF is located in a specific area at the back/side of the brain involving certain large blood vessels (the sigmoid, lateral, or posterior longitudinal sinus)
- The abnormal connection is small enough to be treated with no more than two small mesh tubes (stents)
- If you are a woman who could become pregnant, you must use reliable contraception throughout the study
- You are covered by health insurance
- You are willing and able to sign a consent form agreeing to take part
Who may not be able to join:
- Your DAVF cannot be treated through a minimally invasive procedure through the blood vessels
- Your DAVF is a more severe type (Type IIb or higher on the standard classification scale)
- Your DAVF involves a blood vessel that is too narrow or blocked to allow placement of a stent
- You have had inflammation or a blood clot in the affected blood vessel within the last 3 months
- Your DAVF has already been treated with surgery or radiation therapy
- You have more than one DAVF
- The large blood vessel on the opposite side of the head is absent or blocked
- You have a medical reason that prevents you from using the specific stent device used in this trial (confirm with trial site)
- You are currently taking part in another clinical study testing a medical device
- You are unable to attend follow-up appointments at the trial centre at 6 months
- You have a known allergy to heparin, aspirin, warfarin, or other blood-thinning or antiplatelet medications
- You have had any surgery or minimally invasive procedure in the 30 days before the study procedure
- You have had a bleed in or around your brain in the 30 days before the study procedure
- You have a known serious allergy to the dye used in medical scans (contrast agents)
- You have a known sensitivity or allergy to nickel, titanium, or related metals (which are used in the stent)
- You have significant kidney problems, as shown by specific blood test results (confirm with trial site for exact values)
- You have any reason that prevents you from having an MRI scan or blood vessel scan
- You are pregnant, breastfeeding, or planning to become pregnant during the study period
- You are unable to understand what the study involves or are unwilling to sign a consent form
- You are under legal guardianship or protection
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33 556 79 56 04
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cognard's classification grade
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.